- Home
- CNTA vs PRVA Comparison
CNTA vs PRVA Comparison
Compare CNTA & PRVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTA
- PRVA
- Stock Information
- Founded
- CNTA 2020
- PRVA 2007
- Country
- CNTA United Kingdom
- PRVA United States
- Employees
- CNTA N/A
- PRVA N/A
- Industry
- CNTA Biotechnology: Pharmaceutical Preparations
- PRVA Retail: Computer Software & Peripheral Equipment
- Sector
- CNTA Health Care
- PRVA Technology
- Exchange
- CNTA Nasdaq
- PRVA Nasdaq
- Market Cap
- CNTA 2.3B
- PRVA 2.3B
- IPO Year
- CNTA 2021
- PRVA 2021
- Fundamental
- Price
- CNTA $16.46
- PRVA $22.73
- Analyst Decision
- CNTA Strong Buy
- PRVA Strong Buy
- Analyst Count
- CNTA 8
- PRVA 16
- Target Price
- CNTA $23.71
- PRVA $24.63
- AVG Volume (30 Days)
- CNTA 470.8K
- PRVA 628.4K
- Earning Date
- CNTA 11-12-2024
- PRVA 02-25-2025
- Dividend Yield
- CNTA N/A
- PRVA N/A
- EPS Growth
- CNTA N/A
- PRVA N/A
- EPS
- CNTA N/A
- PRVA 0.11
- Revenue
- CNTA $6,853,000.00
- PRVA $1,716,318,000.00
- Revenue This Year
- CNTA N/A
- PRVA $78.50
- Revenue Next Year
- CNTA N/A
- PRVA $11.52
- P/E Ratio
- CNTA N/A
- PRVA $212.13
- Revenue Growth
- CNTA N/A
- PRVA 8.54
- 52 Week Low
- CNTA $7.38
- PRVA $15.92
- 52 Week High
- CNTA $18.97
- PRVA $23.24
- Technical
- Relative Strength Index (RSI)
- CNTA 50.86
- PRVA 69.75
- Support Level
- CNTA $14.61
- PRVA $19.74
- Resistance Level
- CNTA $17.65
- PRVA $21.48
- Average True Range (ATR)
- CNTA 1.08
- PRVA 0.77
- MACD
- CNTA -0.10
- PRVA 0.29
- Stochastic Oscillator
- CNTA 56.74
- PRVA 90.84
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.
About PRVA Privia Health Group Inc.
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.